TMDX
$119.07
Revenue | $157.37Mn |
Net Profits | $34.91Mn |
Net Profit Margins | 22.18% |
PE Ratio | 57.43 |
Transmedics Group Inc’s revenue jumped 37.68% since last year same period to $157.37Mn in the Q2 2025. On a quarterly growth basis, Transmedics Group Inc has generated 9.64% jump in its revenue since last 3-months.
Transmedics Group Inc’s net profit jumped 186.26% since last year same period to $34.91Mn in the Q2 2025. On a quarterly growth basis, Transmedics Group Inc has generated 35.92% jump in its net profits since last 3-months.
Transmedics Group Inc’s net profit margin jumped 107.93% since last year same period to 22.18% in the Q2 2025. On a quarterly growth basis, Transmedics Group Inc has generated 23.97% jump in its net profit margins since last 3-months.
Transmedics Group Inc’s price-to-earnings ratio after this Q2 2025 earnings stands at 57.43.
EPS Estimate Current Quarter | 0.36 |
EPS Estimate Current Year | 0.36 |
Transmedics Group Inc’s earning per share (EPS) estimates for the current quarter stand at 0.36 - a -18.46% fall from last quarter’s estimates.
Transmedics Group Inc’s earning per share (EPS) estimates for the current year stand at 0.36.
Earning Per Share (EPS) | 0 |
Transmedics Group Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Transmedics Group Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-07-30 | 0.45 | 0.92 | 106.6% |
2025-11-11 | 0.36 | 0 | -100% |
2025-05-08 | 0.24 | 0.7 | 190.1% |